Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
5,555,556
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
528,456
-
Shares change
-
+10,983
-
Total reported value, excl. options
-
$1,670,206
-
Value change
-
+$34,959
-
Number of buys
-
6
-
Number of sells
-
8
-
Price
-
$3.16
Institutional Holders of Lipocine Inc. - Common Stock, par value $0.0001 per share (LPCN) as of Q2 2025
As of 30 Jun 2025 Lipocine Inc. - Common Stock, par value $0.0001 per share (LPCN) had 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 528,456 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, RENAISSANCE TECHNOLOGIES LLC, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, NORTHERN TRUST CORP, BARCLAYS PLC, and BANK OF AMERICA CORP /DE/.
This table shows 18 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.